CIDARA THERAPEUTICS, INC. Restricted Cash
CIDARA THERAPEUTICS, INC. had Restricted Cash of $6.34 million as of 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2025-08-07
- 2025-06-30: Restricted Cash $6.34M.
- 2025-03-31: Restricted Cash $6.34M.
- 2024-12-31: Restricted Cash $6.35M.
- 2023-06-30: Restricted Cash $0.00.
| Period end | Restricted Cash |
|---|---|
| 2025-06-30 | $6.34M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $6.34M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $6.35M 10-Q · filed 2025-08-07 |
| 2023-06-30 | $0.00 10-K · filed 2024-04-22 |
| 2023-03-31 | $0.00 10-K · filed 2024-04-22 |
| 2022-06-30 | $370.00K 10-K · filed 2024-04-22 |
| 2022-03-31 | $1.48M 10-K · filed 2024-04-22 |
| 2021-12-31 | $2.59M 10-K · filed 2023-03-23 |
| 2021-09-30 | $3.70M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $4.82M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $5.93M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $7.04M 10-Q · filed 2021-11-10 |
| 2020-09-30 | $8.15M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $9.26M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $10.00M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $10.00M 10-Q · filed 2020-11-05 |